KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is teaching a community group about how new
medications become available for clinical use. Which statement
by a participant indicates correct understanding?
A. "A medication can be marketed after laboratory testing if no
serious toxicity is identified."
B. "Human clinical trials generally occur in phases that evaluate
safety, dosing, efficacy, and post-marketing outcomes."
C. "Once a drug receives approval, additional monitoring for
adverse effects is no longer required."
D. "Animal studies provide enough evidence to replace testing
in human volunteers."
Correct Answer: B
Rationale:
Clinical drug development typically includes multiple phases
that assess safety, pharmacokinetics, dosing, efficacy, and long-
term or rare adverse effects through post-marketing
surveillance. Option A is incorrect because laboratory testing
alone is insufficient for approval. Option C is incorrect because
ongoing pharmacovigilance remains essential after approval.
Option D is incorrect because animal studies cannot fully
predict human responses and do not replace human clinical
trials.
,Question 2
A nurse administers a medication that produces a desired effect
after binding to a specific receptor. Which concept best
describes this interaction?
A. Pharmacokinetics
B. Pharmacodynamics
C. Bioavailability
D. First-pass metabolism
Correct Answer: B
Rationale:
Pharmacodynamics refers to what a drug does to the body,
including receptor interactions, mechanisms of action, and
physiological effects. Pharmacokinetics describes absorption,
distribution, metabolism, and excretion. Bioavailability concerns
the fraction of administered drug reaching systemic circulation.
First-pass metabolism refers to hepatic metabolism occurring
before a drug reaches systemic circulation.
Question 3
A patient asks why two individuals taking the same medication
may experience different responses. Which nursing explanation
is most appropriate?
A. "Drug effects are determined solely by body weight."
, B. "Individual responses may vary because of genetics, age,
organ function, and other medications."
C. "All approved medications produce identical effects in every
person."
D. "Differences in response occur only when patients do not
take the drug as prescribed."
Correct Answer: B
Rationale:
Drug responses are influenced by genetic factors, age, liver and
kidney function, concurrent illnesses, and interactions with
other medications. Body weight alone does not determine
response. Approved drugs still demonstrate interindividual
variability. Although adherence affects outcomes, it is not the
only reason for differing responses.
Question 4
A nurse reviews medication administration principles with a
newly licensed colleague. Which action best supports
medication safety during drug therapy?
A. Relying on memory for high-alert medication doses
B. Administering unfamiliar medications without reviewing
references
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is teaching a community group about how new
medications become available for clinical use. Which statement
by a participant indicates correct understanding?
A. "A medication can be marketed after laboratory testing if no
serious toxicity is identified."
B. "Human clinical trials generally occur in phases that evaluate
safety, dosing, efficacy, and post-marketing outcomes."
C. "Once a drug receives approval, additional monitoring for
adverse effects is no longer required."
D. "Animal studies provide enough evidence to replace testing
in human volunteers."
Correct Answer: B
Rationale:
Clinical drug development typically includes multiple phases
that assess safety, pharmacokinetics, dosing, efficacy, and long-
term or rare adverse effects through post-marketing
surveillance. Option A is incorrect because laboratory testing
alone is insufficient for approval. Option C is incorrect because
ongoing pharmacovigilance remains essential after approval.
Option D is incorrect because animal studies cannot fully
predict human responses and do not replace human clinical
trials.
,Question 2
A nurse administers a medication that produces a desired effect
after binding to a specific receptor. Which concept best
describes this interaction?
A. Pharmacokinetics
B. Pharmacodynamics
C. Bioavailability
D. First-pass metabolism
Correct Answer: B
Rationale:
Pharmacodynamics refers to what a drug does to the body,
including receptor interactions, mechanisms of action, and
physiological effects. Pharmacokinetics describes absorption,
distribution, metabolism, and excretion. Bioavailability concerns
the fraction of administered drug reaching systemic circulation.
First-pass metabolism refers to hepatic metabolism occurring
before a drug reaches systemic circulation.
Question 3
A patient asks why two individuals taking the same medication
may experience different responses. Which nursing explanation
is most appropriate?
A. "Drug effects are determined solely by body weight."
, B. "Individual responses may vary because of genetics, age,
organ function, and other medications."
C. "All approved medications produce identical effects in every
person."
D. "Differences in response occur only when patients do not
take the drug as prescribed."
Correct Answer: B
Rationale:
Drug responses are influenced by genetic factors, age, liver and
kidney function, concurrent illnesses, and interactions with
other medications. Body weight alone does not determine
response. Approved drugs still demonstrate interindividual
variability. Although adherence affects outcomes, it is not the
only reason for differing responses.
Question 4
A nurse reviews medication administration principles with a
newly licensed colleague. Which action best supports
medication safety during drug therapy?
A. Relying on memory for high-alert medication doses
B. Administering unfamiliar medications without reviewing
references
